Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
interleukin 8 | 2 | 0 | 0 | 2 |
TDP1 protein | 7 | 0 | 0 | 7 |
AR protein | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
progesterone receptor | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
IDH1 | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
geminin | 7 | 0 | 0 | 7 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 4 | 0 | 3 | 0 | 3 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 1 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 3 | 1 | 5 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Luciferase | 3 | 0 | 0 | 3 |
thioredoxin reductase | 4 | 0 | 0 | 4 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
WRN | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
GLS protein | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
Caspase-7 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
phospholipase A2 precursor | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
snurportin-1 | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
cysteine protease ATG4B isoform a | 0 | 1 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
Free fatty acid receptor 1 | 0 | 0 | 2 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Trypsin | 0 | 2 | 0 | 2 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
Aromatase | 0 | 2 | 0 | 2 |
Tissue factor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Free fatty acid receptor 4 | 0 | 0 | 2 | 2 |
GABA theta subunit | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
green fluorescent protein, partial | 0 | 1 | 0 | 1 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
Histone H2A.x | 2 | 0 | 0 | 2 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 4 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 0 | 1 |
Beta-galactosidase | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 4 |
Cytochrome P450 2C9 | 0 | 4 | 1 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
4-hydroxy-tetrahydrodipicolinate synthase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Serine racemase | 0 | 1 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
Albumin | 0 | 1 | 1 | 2 |
Stromelysin-1 | 0 | 1 | 1 | 2 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
Nicotinamidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Free fatty acid receptor 2 | 0 | 0 | 1 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Alpha-synuclein | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Vitamin D3 receptor | 0 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |